1166 Preclinical evaluation of lintuzumab-Ac225, a CD33 antibody radioconjugate targeting myeloid-derived suppressor cells

• Jason Li,
• Mary Chen,
• Helen Kotanides,
• Sumit Mukherjee,
• Amanda Chin,
• Debbie Lewis,
• Le-Cun Xu,
• Monideepa Roy,
• Patrik Brodin,
• William van der Touw,
• Denis Beckford-Vera

Affiliations

Jason Li

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Mary Chen

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Helen Kotanides

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Sumit Mukherjee

2Albert Einstein College of Medicine, Bronx, NY, USA

Amanda Chin

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Debbie Lewis

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Le-Cun Xu

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Monideepa Roy

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Patrik Brodin

1Actinium Pharmaceuticals, Inc., New York, NY, USA

William van der Touw

1Actinium Pharmaceuticals, Inc., New York, NY, USA

Denis Beckford-Vera

1Actinium Pharmaceuticals, Inc., New York, NY, USA